Case Studies

Healthcare and pharma Competitive Intelligence dashboard

Posted by | Fuld & Company

A US-based healthcare company wanted to explore its options for a clinical drug development strategy that would minimize its time to market. It therefore sought to keep track of all the drug developments in its therapeutic areas to identify key industry learnings.

Objective

To track and analyze all the drug trials and pipelines in their priority therapeutic areas.

Solution

Pipeline overview across regions and pain segments

Dynamic dashboard with key analyses and timelines

  • Worked with the client to understand key analysis requirements and functionalities in terms of drill-downs.
  • Information was collated from various drug, clinical trial, and financial databases, including ClinicalTrials.gov, BCIQ, Global Data, Cortellis, Capital IQ, and Bloomberg.
  • Automated data pipelines and ingestion workflows to automate data refresh were created.
  • Various design wireframes were tested in collaboration with the client.
  • A dynamic dashboard with key analyses and timelines for drug trials and discovery was created.

Outcome

  • The dashboard enabled the company to stay updated on key developments related to its therapeutic areas.
  • Gaps and white spaces that could be monetized were identified.

Tools

Tags: , , , , ,

Related Resources

Read More

Targeted deal sourcing delivers 70% closure rate and over $350m in M&A deals for boutique investment bank

A West Coast boutique investment bank engaged Fuld & Company to develop a comprehensive business development plan tailored to its […]

Read More

Market due diligence results in 25% jump in revenues for supercomputing startup

How Fuld helped our PE client’s portfolio company prioritize their target markets Our Private Equity client’s portfolio company, a US-based […]

Read More

How a global food company used due diligence for a potential partnership

Due Diligence for a Potential Partnership “This is all great. Thank you so much to the entire team for the work […]

Subscribe to our mailing list for our latest updates:

Subscribe Now